11253601

Source:http://linkedlifedata.com/resource/pubmed/id/11253601

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0441767, umls-concept:C0684249
pubmed:issue	1
pubmed:dateCreated	2001-3-19
pubmed:abstractText	The tumors classified under T3 are diverse and usually present a difficult problem; however, with the improvements in surgery, radiation, and systemic therapies described above, a significant improvement in survival and quality of life can be anticipated for the future.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9208495
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1052-3359
pubmed:author	pubmed-author:AllenM SMS, pubmed-author:JettJ RJR, pubmed-author:KozelskyT FTF
pubmed:issnType	Print
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	61-7
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:11253601-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:11253601-Combined Modality Therapy, pubmed-meshheading:11253601-Humans, pubmed-meshheading:11253601-Lung Neoplasms, pubmed-meshheading:11253601-Neoplasm Invasiveness, pubmed-meshheading:11253601-Neoplasm Metastasis, pubmed-meshheading:11253601-Neoplasm Staging
pubmed:year	2001
pubmed:articleTitle	Stage II (T3) lung cancer.
pubmed:affiliation	Division of General Thoracic Surgery, Mayo Foundation, Rochester, Minnesota, USA.
pubmed:publicationType	Journal Article, Review